Carisma Therapeutics Inc Revenue per Employee (CARM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Carisma Therapeutics Inc   (NASDAQ: CARM)
 

Carisma Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Carisma Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,143,022, below the company average number of $300,975.
Within the Healthcare sector Carisma Therapeutics Inc achieved the highest revenue per employee. While Carisma Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1. Carisma Therapeutics Inc has 46 employees.


What is Sales per Employee Ratio?







CARM Revenue per Employee (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Revenue Change 1236.78 % - 9.77 % -16.28 % -11.55 %
Sales per Employee (TTM) $ 1,143,022 232,913 432,848 425,630 440,848
CARM's Total Ranking # 1 # 0 # 1473 # 1510 # 1499
Seq. Revenue Change - - 3.58 % 6.35 % -63.19 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 0
Healthcare Sector # 0
Overall Market # 1

Revenue per Employee Statistics
High Average Low
$ 1,100,652 $ 300,975 $ 8,826
(Sep 30 2023)   (Dec 31 2016)



Financial Statements
Carisma Therapeutics Inc 's Revenue MRQ $ 45 Millions Visit CARM's Income Statement
Carisma Therapeutics Inc 's Revenues TTM $ 53 Millions Visit CARM's aggregate revenue growth
What are CARM's Sales? Visit CARM's Sales by Segment




Other Ratios
Carisma Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CARM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CARM's Competitors
Revenue per Employee for CARM's Suppliers
Revenue per Employee for CARM's Customers

You may also want to know
CARM's Sales Growth Rates CARM's Pe Price to earnings ratio CARM's Receivables Turnover Ratio CARM's Stock Quote
CARM's Net Income Growth Rates CARM's Ps Price to Sales ratio CARM's Sales per Employee CARM's Asset Turnover Ratio
CARM's Net Margin CARM's Pb Price to Book ratio CARM's Financial Strength Ratios CARM's Dividend Payout Ratio
Date modified: 2026-08-29T17:17:20+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025
Exelixis Inc   1,994,959.02 $ 2,288.218  Million 1,147 
Prestige Consumer Healthcare Inc   1,947,314.04 $ 1,109.969  Million 570 
Elite Pharmaceuticals Inc   1,872,514.65 $ 121.713  Million 65 
Evoke Pharma Inc   1,803,081.50 $ 14.425  Million
Ptc Therapeutics inc   1,795,307.77 $ 1,779.150  Million 991 
Collegium Pharmaceutical Inc   1,786,827.42 $ 755.828  Million 423 
Gilead Sciences Inc   1,711,000.00 $ 29,087.000  Million 17,000 
Incyte Corporation  1,692,371.66 $ 4,813.105  Million 2,844 
Privia Health Group Inc   1,666,043.23 $ 2,042.569  Million 1,226 
Cytomx Therapeutics Inc   1,646,826.09 $ 113.631  Million 69 
Kiniksa Pharmaceuticals International Plc  1,633,806.01 $ 597.973  Million 366 
Anaptysbio Inc   1,629,490.38 $ 169.467  Million 104 
Spero Therapeutics Inc   1,621,960.00 $ 40.549  Million 25 
Rigel Pharmaceuticals Inc  1,621,126.44 $ 282.076  Million 174 
Avadel Pharmaceuticals Plc  1,615,337.66 $ 248.762  Million 154 
Eton Pharmaceuticals Inc   1,593,545.45 $ 70.116  Million 44 
Protagonist Therapeutics inc   1,584,977.27 $ 209.217  Million 132 
Progyny Inc   1,481,349.30 $ 1,268.035  Million 856 
Bristol myers Squibb Company  1,477,969.23 $ 48,034.000  Million 32,500 
Jazz Pharmaceuticals Plc  1,438,696.54 $ 4,157.833  Million 2,890 
Xenetic Biosciences Inc   1,429,467.50 $ 2.859  Million
Novavax inc   1,421,429.91 $ 1,064.651  Million 749 
Zevra Therapeutics Inc   1,383,409.84 $ 84.388  Million 61 
Biocryst Pharmaceuticals Inc   1,378,887.36 $ 599.816  Million 435 
Apellis Pharmaceuticals Inc   1,375,366.71 $ 1,016.396  Million 739 
Keenova Therapeutics Plc  1,370,000.00 $ 2,192.000  Million 1,600 
Biogen Inc   1,342,120.00 $ 10,065.900  Million 7,500 
Neurocrine Biosciences Inc   1,341,350.00 $ 2,682.700  Million 2,000 
Tg Therapeutics Inc   1,333,077.69 $ 531.898  Million 399 
Agenus Inc  1,318,876.54 $ 106.829  Million 81 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.